Clinical trial · Interventional
Split-dose Versus Single-dose Bowel Preparation for Colonoscopy
NCT06426745CI-TRIAL-00077413completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Colonoscopy is the current standard method for evaluation of colonic disorders such as colorectal cancer, IBD, polyps, and other conditions.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colonic Cancer | — | UNRESOLVED | — |
| Colonic Polyp | — | UNRESOLVED | — |
| IBS - Irritable Bowel Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bowel preparation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Split-dose bowel preparation
- description
- About 90 participants underwent Split-dose bowel preparation for colonoscopy
- interventionNames
- Procedure: Bowel preparation
- type
- EXPERIMENTAL
- label
- single-dose bowel preparation
- description
- About 90 participants underwent single-dose bowel preparation for colonoscopy
- interventionNames
- Procedure: Bowel preparation
Primary outcomes (1)
- measure
- colon cleansing
- timeFrame
- 2 hours before Bowel Preparation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: \- All patients undergoing elective colonoscopy Exclusion Criteria: * Presence of sever renal impairment. (Creatinine clearance \< 30 ml/min or patient on hemodialysis). * Sever congestive heart failure (NHYA III or IV). * Pregnant woman. * History of bowel obstruction or resection. * Known allergies to polyethylene glycol. * Refusal of consent for the study. * Signs of liver cell failure as ascites and hepatic encephalopathy. * Electrolytes disturbances
References
Publications (0)
Data not yet available
No reference posted for this study.